Efficient loading of dendritic cells following cryo and radiofrequency ablation in combination with immune modulation induces anti-tumour immunity

British Journal of Cancer

Volumn 95, Issue 7, 2006, Pages 896-905

  Den Brok, M H M G M ^a,b   Sutmuller, R P M ^a   Nierkens, S ^a   Bennink, E J ^a   Frielink, C ^b   Toonen, L W J ^a   Boerman, O C ^b   Figdor, C G ^a   Ruers, T J M ^b   Adema, G J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cryo ablation; CTLA 4; Dendritic cell; Radiofrequency ablation; Regulatory T cell; Vaccination

Indexed keywords

DENDRITIC CELL VACCINE;

ADOPTIVE IMMUNOTHERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN DETECTION; ANTIGEN PRESENTING CELL; ARTICLE; CANCER CELL DESTRUCTION; CANCER COMBINATION CHEMOTHERAPY; CANCER IMMUNOLOGY; CD8+ T LYMPHOCYTE; CELL MATURATION; CONTROLLED STUDY; CRYOTHERAPY; DENDRITIC CELL; FEMALE; IMMUNOMODULATION; LYMPH NODE; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; REGULATORY T LYMPHOCYTE; T CELL DEPLETION;

ANIMALS; ANTIGENS, NEOPLASM; CANCER VACCINES; CATHETER ABLATION; CELL DIFFERENTIATION; CRYOSURGERY; DENDRITIC CELLS; FEMALE; FLOW CYTOMETRY; IMMUNOTHERAPY; LYMPH NODES; LYMPHOCYTE DEPLETION; MICE; MICE, INBRED C57BL; NEOPLASMS, EXPERIMENTAL;

EID: 33749353175     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6603341     Document Type: Article

References (40)

1. Adams S, O'Neill DW, Bhardwaj N (2005) Recent advances in dendritic cell biology. J Clin Immunol 25: 87-98
2. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, Pulendran B, Palucka K (2000) Immunobiology of dendritic cells. Annu Rev Immunol 18: 767-811
3. Banchereau J, Palucka AK (2005) Dendritic cells as therapeutic vaccines against cancer. Nat Rev Immunol 5: 296-306
4. Chen L, Ashe S, Brady WA, Hellstrom I, Hellstrom KE, Ledbetter JA, McGowan P, Linsley PS (1992) Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4. Cell 71: 1093-1102
5. Coulie PG, van der Bruggen P (2003) T-cell responses of vaccinated cancer patients. Curr Opin Immunol 15: 131-137
6. Curley SA (2003) Radiofrequency ablation of malignant liver tumors. Ann Surg Oncol 10: 338-347
7. de Jong KP, von Geusau BA, Rottier CA, Bijzet J, Limburg PC, de Vries EG, Fidler V, Slooff MJ (2001) Serum response of hepatocyte growth factor, insulin-like growth factor-I, interleukin-6, and acute phase proteins in patients with colorectal liver metastases treated with partial hepatectomy or cryosurgery. J Hepatol 34: 422-427
8. De Vries IJ, Krooshoop DJ, Scharenborg NM, Lesterhuis WJ, Diepstra JH, Van Muijen GN, Strijk SP, Ruers TJ, Boerman OC, Oyen WJ, Adema GJ, Punt CJ, Figdor CG (2003) Effective migration of antigen-pulsed dendritic cells to lymph nodes in melanoma patients is determined by their maturation state. Cancer Res 63: 12-17
9. den Brok MH, Sutmuller RP, van der Voort R, Bennink EJ, Figdor CG, Ruers TJ, Adema GJ (2004) In situ tumor ablation creates an antigen source for the generation of antitumor immunity. Cancer Res 64: 4024-4029
10. Egen JG, Kuhns MS, Allison JP (2002) CTLA-4: new insights into its biological function and use in tumor immunotherapy. Nat Immunol 3: 611-618
11. Eggert AA, Schreurs MW, Boerman OC, Oyen WJ, de Boer AJ, Punt CJ, Figdor CG, Adema GJ (1999) Biodistribution and vaccine efficiency of murine dendritic cells are dependent on the route of administration. Cancer Res 59: 3340-3345
12. Eggert AA, van der Voort R, Torensma R, Moulin V, Boerman OC, Oyen WJ, Punt CJ, Diepstra H, de Boer AJ, Figdor CG, Adema GJ (2003) Analysis of dendritic cell trafficking using EGFP-transgenic mice. Immunol Lett 89: 17-24
13. Erce C, Parks RW (2003) Interstitial ablative techniques for hepatic tumours. Br J Surg 90: 272-289
14. Falo Jr LD, Kovacsovics-Bankowski M, Thompson K, Rock KL (1995) Targeting antigen into the phagocytic pathway in vivo induces protective tumour immunity. Nat Med 1: 649-653
15. Figdor CG, de Vries IJ, Lesterhuis WJ, Melief CJ (2004) Dendritic cell immunotherapy: mapping the way. Nat Med 10: 475-480
16. Furumoto K, Soares L, Engleman EG, Merad M (2004) Induction of potent antitumor immunity by in situ targeting of intratumoral DCs. J Clin Invest 113: 774-783
17. Garcea G, Lloyd TD, Aylott C, Maddern G, Berry DP (2003) The emergent role of focal liver ablation techniques in the treatment of primary and secondary liver tumours. Eur J Cancer 39: 2150-2164
18. Huang A, McCall JM, Weston MD, Mathur P, Quinn H, Henderson DC, Allen-Mersh TG (2002) Phase I study of percutaneous cryotherapy for colorectal liver metastasis. Br J Surg 89: 303-310
19. Itano AA, McSorley SJ, Reinhardt RL, Ehst BD, Ingulli E, Rudensky AY, Jenkins MK (2003) Distinct dendritic cell populations sequentially present antigen to CD4 T cells and stimulate different aspects of cell-mediated immunity. Immunity 19: 47-57
20. Josien R, Li HL, Ingulli E, Sarma S, Wong BR, Vologodskaia M, Steinman RM, Choi Y (2000) TRANCE, a tumor necrosis factor family member, enhances the longevity and adjuvant properties of dendritic cells in vivo. J Exp Med 191: 495-502
21. Onizuka S, Tawara I, Shimizu J, Sakaguchi S, Fujita T, Nakayama E (1999) Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor alpha) monoclonal antibody. Cancer Res 59: 3128-3133
22. Pasare C, Medzhitov R (2004) Toll-dependent control mechanisms of CD4 T cell activation. Immunity 21: 733-741
23. Raj GV, Reddan DJ, Hoey MB, Polascik TJ (2003) Management of small renal tumors with radiofrequency ablation. Urology 61: 23-29
24. Randolph GJ, Beaulieu S, Lebecque S, Steinman RM, Muller WA (1998) Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking. Science 282: 480-483
25. Rosenberg SA, Yang JC, Restifo NP (2004) Cancer immunotherapy: moving beyond current vaccines. Nat Med 10: 909-915
26. Ruers T, Bleichrodt RP (2002) Treatment of liver metastases, an update on the possibilities and results. Eur J Cancer 38: 1023-1033
27. Ruers TJ, Joosten J, Jager GJ, Wobbes T (2001) Long-term results of treating hepatic colorectal metastases with cryosurgery. Br J Surg 88: 844-849
28. Sakaguchi S (2005) Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 6: 345-352
29. Schuler G, Schuler-Thurner B, Steinman RM (2003) The use of dendritic cells in cancer immunotherapy. Curr Opin Immunol 15: 138-147
30. Shi Y, Evans JE, Rock KL (2003) Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 425: 516-521
31. Somersan S, Larsson M, Fonteneau JF, Basu S, Srivastava P, Bhardwaj N (2001) Primary tumor tissue lysates are enriched in heat shock proteins and induce the maturation of human dendritic cells. J Immunol 167: 4844-4852
32. Sporri R, Reis e Sousa C (2005) Inflammatory mediators are insufficient for full dendritic cell activation and promote expansion of CD4+ T cell populations lacking helper function. Nat Immunol 6: 163-170
33. Steinman RM, Mellman I (2004) Immunotherapy: bewitched, bothered, and bewildered no more. Science 305: 197-200
34. Steinman RM, Pope M (2002) Exploiting dendritic cells to improve vaccine efficacy. J Clin Invest 109: 1519-1526
35. Sutmuller RP, van Duivenvoorde LM, van Elsas A, Schumacher TN, Wildenberg ME, Allison JP, Toes RE, Offringa R, Melief CJ (2001) Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses. J Exp Med 194: 823-832
36. Townsend SE, Allison JP (1993) Tumor rejection after direct costimulation of CD8+ T cells by B7-transfected melanoma cells. Science 259: 368-370
37. Trinchieri G (2003) Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 3: 133-146
38. Veth R, Schreuder B, van Beem H, Pruszczynski M, de Rooy J (2005) Cryosurgery in aggressive, benign, and low-grade malignant bone tumours. Lancet Oncol 6: 25-34
39. Vremec D, Pooley J, Hochrein H, Wu L, Shortman K (2000) CD4 and CD8 expression by dendritic cell subtypes in mouse thymus and spleen. J Immunol 164: 2978-2986
40. Zagoria RJ, Chen MY, Kavanagh PV, Torti FM (2001) Radio frequency ablation of lung metastases from renal cell carcinoma. J Urol 166: 1827-1828